1. Home
  2. PPBT vs NURO Comparison

PPBT vs NURO Comparison

Compare PPBT & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • NURO
  • Stock Information
  • Founded
  • PPBT 2010
  • NURO 1996
  • Country
  • PPBT Israel
  • NURO United States
  • Employees
  • PPBT N/A
  • NURO N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • NURO Medical/Dental Instruments
  • Sector
  • PPBT Health Care
  • NURO Health Care
  • Exchange
  • PPBT Nasdaq
  • NURO Nasdaq
  • Market Cap
  • PPBT 6.7M
  • NURO 7.6M
  • IPO Year
  • PPBT N/A
  • NURO N/A
  • Fundamental
  • Price
  • PPBT $3.61
  • NURO $3.86
  • Analyst Decision
  • PPBT Strong Buy
  • NURO
  • Analyst Count
  • PPBT 2
  • NURO 0
  • Target Price
  • PPBT $126.50
  • NURO N/A
  • AVG Volume (30 Days)
  • PPBT 2.7M
  • NURO 23.4K
  • Earning Date
  • PPBT 11-15-2024
  • NURO 11-05-2024
  • Dividend Yield
  • PPBT N/A
  • NURO N/A
  • EPS Growth
  • PPBT N/A
  • NURO N/A
  • EPS
  • PPBT N/A
  • NURO N/A
  • Revenue
  • PPBT N/A
  • NURO $3,767,764.00
  • Revenue This Year
  • PPBT N/A
  • NURO N/A
  • Revenue Next Year
  • PPBT N/A
  • NURO N/A
  • P/E Ratio
  • PPBT N/A
  • NURO N/A
  • Revenue Growth
  • PPBT N/A
  • NURO N/A
  • 52 Week Low
  • PPBT $2.00
  • NURO $2.66
  • 52 Week High
  • PPBT $20.60
  • NURO $4.73
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 47.73
  • NURO 51.55
  • Support Level
  • PPBT $3.56
  • NURO $3.63
  • Resistance Level
  • PPBT $4.22
  • NURO $4.07
  • Average True Range (ATR)
  • PPBT 1.42
  • NURO 0.24
  • MACD
  • PPBT -0.07
  • NURO -0.03
  • Stochastic Oscillator
  • PPBT 3.36
  • NURO 56.09

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: